Full course description

About this course

Precision Medicine for Your Practice is a series of short (20-30 min), online modules covering specific topics in genomics and precision medicine. In this module, Genomic Testing for the Healthy Individual, learn how to elicit patient motivations for genomic testing and to assess if a particular genomic test is a good fit for their concerns. This module will help providers understand the benefits and limitations of different types of genomic tests, know what types of information are available from different types of tests, and increase provider awareness of resources available to help interpret and prioritize results from genomic testing. There are five parts of the module: overview via an animated video; practice cases to facilitate learning-by-doing; "dig deeper" for more in-depth topics; and logistics and additional resources for more detail.

Already enrolled? Access the course here.

Activity Overview

Release Date: January 6, 2018
Expiration Date: January, 2021

Objectives
Upon completion of this educational activity, the learner will be able to:

  • Identify patient motivators to enable decisions regarding genomic testing. 
  • Facilitate interpretation of genomic test results from a wide range of test types, including those with lower clinical validity and utility.

Statement of Need

Genetic technology is rapidly expanding, often too quickly for physicians and other health professionals to become familiar with new technologies and new genomic information before their patients inquire about genomic testing. This educational module will assist physicians and health professionals to communicate with patients about the benefits, risks, and limitations of genomic testing in healthy individuals.  

Statement of Competency

This activity is designed to address the following ABMS/ACGME competencies: patient care, medical knowledge, and interpersonal and communication skills.

Accreditation Statement

The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement

The American Medical Association designates this enduring material for a maximum of .50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Claiming Your CME Credit

In order to claim AMA PRA Category 1 Credit™, you must: 1) answer the pre-assessment questions, 2) work through the module in its entirety, 3) successfully complete the post-assessment by answering 2 out of 3 questions correctly and 4) complete the evaluation.

Planning Committee

  • Barry D. Dickinson, PhD, CME Program Committee, AMA
  • Abdallah Elias, MD, Department of Medical Genetics, Shodair Children's Hospital
  • Jeanette McCarthy, MPH, PhD, Visiting Associate Professor, Division of Medical Genetics, UCSF School of Medicine
  • Laura Nicholson, MD, Co-Director of Education, Scripps Translational Science Institute
  • James O'Leary, MBA, Chief innovation Officer, Genetic Alliance
  • Janet K. Williams, PhD, RN, FAAN, Professor of Nursing, Chair of Behavioral and Social Science Research, University of Iowa

 

Faculty

  • Barry D. Dickinson, PhD, CME Program Committee, AMA (Content Reviewer)
  • Emily Edelman, MS, CGC, Associate Director, Clinical and Continuing Education, The Jackson Laboratory (Author)
  • Therese Ingram Nissen, MA, Senior Instructional Designer/Technologist, The Jackson Laboratory (Author)
  • Laura Nicholson, MD, Co-Director of Education, Scripps Translational Science Institute (Author)
  • Kate Reed, MPH, ScM, CGC, Director, Clinical and Continuing Education, The Jackson Laboratory (Author)
  • Linda Steinmark, MS, CGC, Project Director, Clinical and Continuing Education, The Jackson Laboratory (Author)
  • Janet K. Williams, PhD, RN, FAAN, Professor of Nursing, Chair of Behavioral and Social Science Research, University of Iowa (Content Reviewer)

Disclosure Statement

In order to assure the highest quality of certified CME programming, and to comply with the ACCME Standards for Commercial Support, the AMA requires that all faculty, planners and members of the AMA CME Program Committee disclose relevant financial relationships with any commercial or proprietary entity producing health care goods or services relevant to the content being planned or presented. The following disclosures are provided:

  • Jeanette McCarthy, PhD, MPH, Consultant to Big Science Media, Omicia, and Precision Medicine Advisors
  • Janet K. Williams, PhD, RN, FAAN, Stockholder of Pfizer

No other planners or faculty have relevant financial relationships to disclose.

References

American College of Medical Genetics and Genomics. Clinical utility of genetic and genomic services: a position statement. Genet Med. 2015; 17(6):505-507.

American College of Medical Genetics and Genomics. Direct-to-consumer genetic testing: a revised position statement. Genet Med. 2015; 18(2):207-208.

American College of Medical Genetics and Genomics. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement. Genet Med. 2016; 19(2):249-255.

Baptista NM, Christensen KD, Carere DA, Broadley SA, Roberts JS, Green RC. Adopting genetics: motivations and outcomes of personal genomic testing in adult adoptees. Genet Med. 2016; 18(9):924-932.

Bunnik EM, Janssens ACJW, Schermer MHN. Personal utility in genomic testing: is there such a thing? J Med Ethics. 2015; 41(4):322-326.

Garrison NA, Non AL. Direct-to-Consumer Genomics Companies Should Provide Guidance to Their Customers on (Not) Sharing Personal Genomic Information. The American Journal of Bioethics. 2014; 14(11):55-57.

Kirkpatrick BE, Rashkin MD. Ancestry Testing and the Practice of Genetic Counseling. J Genet Counsel. 2016; 26(1):6-20.

Kozlovskaia M, Vlahovich N, Ashton KJ, Hughes DC. Biomedical Risk Factors of Achilles Tendinopathy in Physically Active People: a Systematic Review. Sports Med - Open. 2017; 3(1):20-33.

Linderman M, Nielsen D, Green R. Personal Genome Sequencing in Ostensibly Healthy Individuals and the PeopleSeq Consortium. 2016; 6(2):14-29.

Lindor NM, Thibodeau SN, Burke W. Whole-Genome Sequencing in Healthy People. Mayo Clinic Proceedings. 2017; 92(1):159-172.

Lu M, Lewis CM, Traylor M. Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe. BMC Med Genomics. 2017; 10(1):47-54.

Lupo PJ, Robinson JO, Diamond PM et al. Patients’ perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project. Personalized Medicine. 2016; 13(1):13-20.

Niemiec E, Howard HC. Ethical issues in consumer genome sequencing: Use of consumers' samples and data. Applied & Translational Genomics. 2016; 8:23-30.

Ostergren JE, Gornick MC, Carere DA et al. How Well Do Customers of Direct-to-Consumer Personal Genomic Testing Services Comprehend Genetic Test Results? Findings from the Impact of Personal Genomics Study. Public Health Genomics. 2015; 18(4):216-224.

Topol E. Individualized Medicine from Pre-womb to Tomb. 2014; 157(1):241-253.

Vassy JL, Christensen KD, Schonman EF et al. The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients. Ann Intern Med. 2017; 167(3):159-70.

Wang L, McLeod HL, Weinshilboum RM. Genomics and Drug Response. N Engl J Med. 2011; 364(12):1144-1153.

Wasson K, Sanders TN, Hogan NS, Cherny S, Helzlsouer KJ. Primary care patients’ views and decisions about, experience of and reactions to direct-to-consumer genetic testing: a longitudinal study. J Community Genet. 2013; 4(4):495-505.

 

Hardware/software Requirements

Audio speakers or headphones
Screen resolution of 800X600 or higher
Adobe Reader 5.0 or higher 

As of June 4, 2016, we support the following versions of Flash and popular web browsers:

Operating Systems

  • Windows 7 and newer
  • Mac OSX 10.6 and newer
  • Linux - chromeOS

Mobile Operating System Native App Support

  • iOS 7 and newer
  • Android 4.2 and newer

Should you have questions regarding the content of the activity or if you need technical support, please email Clinical and Continuing Education at the Jackson Laboratory.